Valerie G Press1, Vineet M Arora2, Kristin C Trela3, Richa Adhikari1, Frank J Zadravecz4, Chuanhong Liao5, Edward Naureckas6, Steven R White6, David O Meltzer1, Jerry A Krishnan7. 1. 1 Section of Hospital Medicine, Department of Medicine. 2. 2 Section of General Internal Medicine, Department of Medicine. 3. 3 University of Michigan Medical School, Ann Arbor, Michigan. 4. 4 University of Illinois at Chicago College of Medicine, Chicago, Illinois; and. 5. 5 Department of Public Health Sciences, University of Chicago, Chicago, Illinois. 6. 6 Section of Pulmonary and Critical Care Medicine, Department of Medicine, and. 7. 7 Division of Pulmonary, Critical Care, Sleep, and Allergy, Department of Medicine, University of Illinois at Chicago College of Medicine, Chicago, Illinois.
Abstract
RATIONALE: The most effective approach to teaching respiratory inhaler technique is unknown. OBJECTIVES: To evaluate the relative effects of two different educational strategies (teach-to-goal instruction vs. brief verbal instruction) in adults hospitalized with asthma or chronic obstructive pulmonary disease. METHODS: We conducted a randomized clinical trial at two urban academic hospitals. Participants received teach-to-goal or brief instruction in the hospital and were followed for 90 days after discharge. Inhaler technique was assessed using standardized checklists; misuse was defined as 75% steps or less correct (≤9 of 12 steps). The primary outcome was metered-dose inhaler misuse 30 days postdischarge. Secondary outcomes included Diskus technique; acute care events at 30 and 90 days; and associations with adherence, health literacy, site, and patient risk (near-fatal event). MEASUREMENTS AND MAIN RESULTS:Of 120 participants, 73% were female and 90% were African American. Before education, metered-dose inhaler misuse was similarly common in the teach-to-goal and brief intervention groups (92% vs. 84%, respectively; P = 0.2). Metered-dose inhaler misuse was not significantly less common in the teach-to-goal group than in the brief instruction group at 30 days (54% vs. 70%, respectively; P = 0.11), but it was immediately after education (11% vs. 60%, respectively; P < 0.001) and at 90 days (48% vs. 76%, respectively; P = 0.003). Similar results were found with the Diskus device. Participants did not differ across education groups with regard to rescue metered-dose inhaler use or Diskus device adherence at 30 or 90 days. Acute care events were less common among teach-to-goal participants than brief intervention participants at 30 days (17% vs. 36%, respectively; P = 0.02), but not at 90 days (34% vs. 38%, respectively; P = 0.6). Participants with low health literacy receiving teach-to-goal instruction were less likely than brief instruction participants to report acute care events within 30 days (15% vs. 70%, respectively; P = 0.008). No differences existed by site or patient risk at 30 or 90 days (P > 0.05). CONCLUSIONS: In adults hospitalized with asthma or chronic obstructive pulmonary disease, in-hospital teach-to-goal instruction in inhaler technique did not reduce inhaler misuse at 30 days, but it was associated with fewer acute care events within 30 days after discharge. Inpatient treatment-to-goal education may be an important first step toward improving self-management and health outcomes for hospitalized patients with asthma or chronic obstructive pulmonary disease, especially among patients with lower levels of health literacy. Clinical trial registered with www.clinicaltrials.gov (NCT01426581).
RCT Entities:
RATIONALE: The most effective approach to teaching respiratory inhaler technique is unknown. OBJECTIVES: To evaluate the relative effects of two different educational strategies (teach-to-goal instruction vs. brief verbal instruction) in adults hospitalized with asthma or chronic obstructive pulmonary disease. METHODS: We conducted a randomized clinical trial at two urban academic hospitals. Participants received teach-to-goal or brief instruction in the hospital and were followed for 90 days after discharge. Inhaler technique was assessed using standardized checklists; misuse was defined as 75% steps or less correct (≤9 of 12 steps). The primary outcome was metered-dose inhaler misuse 30 days postdischarge. Secondary outcomes included Diskus technique; acute care events at 30 and 90 days; and associations with adherence, health literacy, site, and patient risk (near-fatal event). MEASUREMENTS AND MAIN RESULTS: Of 120 participants, 73% were female and 90% were African American. Before education, metered-dose inhaler misuse was similarly common in the teach-to-goal and brief intervention groups (92% vs. 84%, respectively; P = 0.2). Metered-dose inhaler misuse was not significantly less common in the teach-to-goal group than in the brief instruction group at 30 days (54% vs. 70%, respectively; P = 0.11), but it was immediately after education (11% vs. 60%, respectively; P < 0.001) and at 90 days (48% vs. 76%, respectively; P = 0.003). Similar results were found with the Diskus device. Participants did not differ across education groups with regard to rescue metered-dose inhaler use or Diskus device adherence at 30 or 90 days. Acute care events were less common among teach-to-goal participants than brief intervention participants at 30 days (17% vs. 36%, respectively; P = 0.02), but not at 90 days (34% vs. 38%, respectively; P = 0.6). Participants with low health literacy receiving teach-to-goal instruction were less likely than brief instruction participants to report acute care events within 30 days (15% vs. 70%, respectively; P = 0.008). No differences existed by site or patient risk at 30 or 90 days (P > 0.05). CONCLUSIONS: In adults hospitalized with asthma or chronic obstructive pulmonary disease, in-hospital teach-to-goal instruction in inhaler technique did not reduce inhaler misuse at 30 days, but it was associated with fewer acute care events within 30 days after discharge. Inpatient treatment-to-goal education may be an important first step toward improving self-management and health outcomes for hospitalized patients with asthma or chronic obstructive pulmonary disease, especially among patients with lower levels of health literacy. Clinical trial registered with www.clinicaltrials.gov (NCT01426581).
Authors: Valerie G Press; Vineet M Arora; Lisa M Shah; Stephanie L Lewis; Jeffery Charbeneau; Edward T Naureckas; Jerry A Krishnan Journal: J Gen Intern Med Date: 2012-05-17 Impact factor: 5.128
Authors: Valerie G Press; Vineet M Arora; Lisa M Shah; Stephanie L Lewis; Krystal Ivy; Jeffery Charbeneau; Sameer Badlani; Edward Nareckas; Edward Naurekas; Antoinette Mazurek; Jerry A Krishnan Journal: J Gen Intern Med Date: 2011-01-20 Impact factor: 5.128
Authors: Bartolomé R Celli; Nicola E Thomas; Julie A Anderson; Gary T Ferguson; Christine R Jenkins; Paul W Jones; Jørgen Vestbo; Katharine Knobil; Julie C Yates; Peter M A Calverley Journal: Am J Respir Crit Care Med Date: 2008-05-29 Impact factor: 21.405
Authors: Matthew F Griffith; Laura C Feemster; Lucas M Donovan; Laura J Spece; Jerry A Krishnan; Peter K Lindenauer; Mary A McBurnie; Richard A Mularski; David H Au Journal: Ann Am Thorac Soc Date: 2019-06
Authors: Byron Thomashow; James D Crapo; M Bradley Drummond; MeiLan K Han; Ravi Kalhan; Elisha Malanga; Vinny Malanga; David M Mannino; Stephen Rennard; Frank C Sciurba; Kristen S Willard; Robert Wise; Barbara Yawn Journal: Chronic Obstr Pulm Dis Date: 2019-07-24
Authors: Robert A Wise; Russell A Acevedo; Antonio R Anzueto; Nicola A Hanania; Fernando J Martinez; Jill A Ohar; Donald P Tashkin Journal: Chronic Obstr Pulm Dis Date: 2016-11-15
Authors: Rachel O'Conor; Kimberly Muellers; Marina Arvanitis; Daniel P Vicencio; Michael S Wolf; Juan P Wisnivesky; Alex D Federman Journal: Respir Med Date: 2019-02-14 Impact factor: 3.415
Authors: Anne C Melzer; Bijan J Ghassemieh; Suzanne E Gillespie; Peter K Lindenauer; Mary Ann McBurnie; Richard A Mularski; Edward T Naureckas; William M Vollmer; David H Au Journal: Respir Med Date: 2016-12-20 Impact factor: 3.415
Authors: Jerry A Krishnan; Molly A Martin; Cortland Lohff; Giselle S Mosnaim; Helen Margellos-Anast; Julie A DeLisa; Kate McMahon; Kim Erwin; Leslie S Zun; Michael L Berbaum; Michael McDermott; Nina E Bracken; Rajesh Kumar; S Margaret Paik; Sharmilee M Nyenhuis; Stacy Ignoffo; Valerie G Press; Zachary E Pittsenbarger; Trevonne M Thompson Journal: Contemp Clin Trials Date: 2017-03-31 Impact factor: 2.226
Authors: Ethan G Jaffee; Vineet M Arora; Madeleine I Matthiesen; Seenu M Hariprasad; David O Meltzer; Valerie G Press Journal: J Health Commun Date: 2016-09-23